Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Metronomic low-dose chemotherapy targeting angiogenesis may help women with early-stage breast cancer
February 2nd, 2006
Metronomic low-dose chemotherapy targeting angiogenesis may help women with early-stage breast cancer. According to scientists writing in the journal Breast, "we have been studying the molecular and cellular basis of chronic low-dose, frequently administered, metronomic chemotherapy regimens for the treatment of cancer in a variety of preclinical models, including human breast cancer xenografts." "The advantages of metronomic-maintenance-type chemotherapy regimens include significantly reduced host toxicity, potentially reduced costs, increased convenience for patients when oral chemotherapy drugs are used, and the possibility of adopting...
Source: Women's Health Weekly (2006-02-02)
|
